Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024 (TILT-2024) by benforred | Jan 21, 2026
Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance by benforred | Jan 21, 2026
Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes by benforred | Jan 21, 2026
Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy by benforred | Jan 20, 2026
A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD) by benforred | Jan 19, 2026
